---
schema_version: "secwatch.filing_event.v1"
accession: "0001501697-26-000060"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2026-07-01T20:13:51+00:00"
generated_at: "2026-07-01T20:15:05.513077+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# X4 Pharmaceuticals appoints Kelly Gold to Board of Directors

## Summary
- Kelly Gold appointed as Class II director effective July 1, 2026; board expands from 5 to 6 members.
- Gold is CFO of CAMP4 Therapeutics (Nasdaq: CAMP) and will serve on Audit Committee.
- Gold brings financial leadership, capital markets expertise, and rare disease experience from Biogen.
- No arrangements or family relationships with other directors/officers; standard compensation per non-employee director policy.

## SEC filing metadata
- accession: 0001501697-26-000060
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2026-07-01T20:13:51+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000150169726000060/0001501697-26-000060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000150169726000060/xfor-20260630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001501697-26-000060
- JSON: https://secwatch.observer/filing/0001501697-26-000060.json
- Plain text: https://secwatch.observer/filing/0001501697-26-000060.txt

## Key facts
- Executive change
  Kelly Gold was appointed as Class II director at X4 Pharmaceuticals, Inc.
  - Action: appointed
  - Role: Class II director
  source text: On June 30, 2026, of X4 Pharmaceuticals, Inc. (the “Company”) appointed Kelly Gold as a Class II director of the Company, effective as of July 1, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501697/000150169726000060/0001501697-26-000060-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.